Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Orawan Thienfaidee"'
Autor:
Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan, Jiratchaya Puenpa, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chulikorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan, Chintana Chirathaworn, Duangnapa Intharasongkroh, Dootchai Chaiwanichsiri, Mila Issarasongkhram, Rungrueng Kitphati, Anek Mungaomklang, Pijaya Nagavajara, Yong Poovorawan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract This study monitored the long-term immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection in patients who had recovered from coronavirus disease (COVID)-19. Anti-nucleocapsid immunoglobulin G (anti-N IgG) tit
Externí odkaz:
https://doaj.org/article/e60e4dbcc0c64a29898266a634977504
Autor:
Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, Nasamon Wanlapakorn, Chintana Chirathaworn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chulikorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan, Duangnapa Intharasongkroh, Dootchai Chaiwanichsiri, Mila Issarasongkhram, Rungrueng Kitphati, Anek Mungaomklang, Arunee Thitithanyanont, Pijaya Nagavajara, Yong Poovorawan
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267102 (2022)
Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to ass
Externí odkaz:
https://doaj.org/article/e4d23c4d7eb54b528a26b70114efe488
Autor:
Chintana Chirathaworn, Manit Sripramote, Piti Chalongviriyalert, Supunnee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chuleekorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan, Dootchai Chaiwanichsiri, Duangnapa Intharasongkroh, Nasamon Wanlapakorn, Jira Chansaenroj, Jiratchaya Puenpa, Ritthideach Yorsaeng, Arunee Thitithanyanont, Rungrueng Kitphati, Anek Mungaomklang, Pijaya Nagavajara, Yong Poovorawan
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0236905 (2020)
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although Thailand has been fairly effective at controlling the spread of COVID-19, continued disease surveillance and information on an
Externí odkaz:
https://doaj.org/article/9af09caf82bd4f8692d7b62d0bf7c4c6
Autor:
Rungrueng Kitphati, Pijaya Nagavajara, Jatuporn Saiyarin, Piti Chalongviriyalert, Supunee Jirajariyavej, Chantapat Brukesawan, Nawarat Posuwan, Chulikorn Soudon, Ritthideach Yorsaeng, Orawan Thienfaidee, Phatharaporn Kiatpanabhikul, Yong Poovorawan, Nasamon Wanlapakorn, Jira Chansaenroj, Anek Mungaomklang, Manit Sripramote, Thitisan Palakawong Na Ayuthaya, Natthinee Sudhinaraset, Chintana Chirathaworn, Jiratchaya Puenpa, Duangnapa Intharasongkroh, Mila Issarasongkhram, Dootchai Chaiwanichsiri
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
This study monitored the long-term immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection in patients who had recovered from coronavirus disease (COVID)-19. Anti-nucleocapsid immunoglobulin G (anti-N IgG) titer in ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f108ccb36a884dc6485be79eedd0ed3
https://doaj.org/article/e60e4dbcc0c64a29898266a634977504
https://doaj.org/article/e60e4dbcc0c64a29898266a634977504
Autor:
Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, Nasamon Wanlapakorn, Chintana Chirathaworn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chulikorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan, Duangnapa Intharasongkroh, Dootchai Chaiwanichsiri, Mila Issarasongkhram, Rungrueng Kitphati, Anek Mungaomklang, Arunee Thitithanyanont, Pijaya Nagavajara, Yong Poovorawan
Publikováno v:
PloS one. 17(4)
Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f08a6f467314cd60dcb613a05f57bda
https://pubmed.ncbi.nlm.nih.gov/35446889
https://pubmed.ncbi.nlm.nih.gov/35446889
Autor:
Mila Issarasongkhram, Orawan Thienfaidee, Supunee Jirajariyavej, Nasamon Wanlapakorn, Chantapat Brukesawan, Jira Chansaenroj, Jatuporn Saiyarin, Anek Mungaomklang, Rungrueng Kitphati, Ritthideach Yorsaeng, Dootchai Chaiwanichsiri, Pijaya Nagavajara, Phatharaporn Kiatpanabhikul, Yong Poovorawan, Piti Chalongviriyalert, Duangnapa Intharasongkroh, Arunee Thitithanyanont, Manit Sripramote, Thitisan Palakawong Na Ayuthaya, Natthinee Sudhinaraset, Chulikorn Soudon, Chintana Chirathaworn
Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule. This study aimed to assess the dynamics of SARS-CoV-2 antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7c6a5c3fd7fe089173776ec199beb02
https://doi.org/10.21203/rs.3.rs-1073046/v1
https://doi.org/10.21203/rs.3.rs-1073046/v1
Autor:
Pijaya Nagavajara, Orawan Thienfaidee, Anek Mungaomklang, Jira Chansaenroj, Jatuporn Saiyarin, Chantapat Brukesawan, Rungrueng Kitphati, Ritthideach Yorsaeng, Nasamon Wanlapakorn, Jiratchaya Puenpa, Phatharaporn Kiatpanabhikul, Yong Poovorawan, Arunee Thitithanyanont, Manit Sripramote, Thitisan Palakawong Na Ayuthaya, Chulikorn Soudon, Chintana Chirathaworn, Dootchai Chaiwanichsiri, Supunee Jirajariyavej, Piti Chalongviriyalert, Duangnapa Intharasongkroh
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 emerged in December 2019 and has spread globally. Although Thailand has been effective at controlling the spread of COVID-19, dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cf6ae6b6b1395555f683030c004e744
https://doi.org/10.1101/2020.07.17.208439
https://doi.org/10.1101/2020.07.17.208439
Autor:
Jiratchaya Puenpa, Supunnee Jirajariyavej, Piti Chalongviriyalert, Orawan Thienfaidee, Jatuporn Saiyarin, Phatharaporn Kiatpanabhikul, Dootchai Chaiwanichsiri, Chintana Chirathaworn, Chantapat Brukesawan, Arunee Thitithanyanont, Manit Sripramote, Thitisan Palakawong Na Ayuthaya, Ritthideach Yorsaeng, Yong Poovorawan, Jira Chansaenroj, Duangnapa Intharasongkroh, Pijaya Nagavajara, Anek Mungaomklang, Rungrueng Kitphati, Chuleekorn Soudon, Nasamon Wanlapakorn
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0236905 (2020)
PLoS ONE, Vol 15, Iss 10, p e0236905 (2020)
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although Thailand has been fairly effective at controlling the spread of COVID-19, continued disease surveillance and information on an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317cb6212a3d54a6026643db066a2568
https://pubmed.ncbi.nlm.nih.gov/33119712
https://pubmed.ncbi.nlm.nih.gov/33119712